Scientific Communication

Scientific Communication

  • Trusted and meticulous preparation
    Original research and comprehensive systematic reviews, ensuring clarity and rigor at every stage.
  • Firmly grounded in scientific excellence
    Delivering work that meets the highest standards of accuracy, transparency, and credibility.
  • Dedicated to precision and reliability
    Supporting evidence-based insights that drive informed decisions and meaningful impact.

Insightful patient journey visuals

  • Evidence-based patient storytelling
    Bringing real experiences to life with clarity and authenticity.
  • Enhances advisory board discussions
    Providing meaningful, data-driven narratives.
  • Strengthens clinical dialogue
    Insights that foster engagement and informed decision-making.

Real-World Evidence as a Service (RWEaaS) provides a practical and scalable way to access experienced real-world evidence (RWE) support, helping teams move faster while maintaining quality and flexibility.

RWEaaS is a flexible model where companies access RWE expertise on demand. It allows organizations to bring in experienced support for a specific study or embed our experienced researchers within internal teams, functioning as part of the team for a defined period, similar to a full-time role, but without the need for permanent hiring.

Compared to traditional RWE consulting, which is often project-based with a fixed scope and timeline, RWEaaS is designed to be adaptable. Support can scale up or down depending on the stage of the project or evolving evidence needs, allowing rapid alignment with shifting priorities.

This model is particularly useful when internal teams face capacity constraints, during hiring gaps, or when specific expertise is needed, for example in Nordic register studies, regulatory-grade RWE generation, or advanced study designs.

RWEaaS can also support the development and execution of an Integrated Evidence Generation Plan, from identifying and prioritizing evidence gaps to translating them into feasible study designs and delivering studies aligned with regulatory and market access requirements across the product lifecycle.

In practice, RWEaaS can support the full evidence generation process, from early planning and strategy through analysis and publication. It complements internal teams, helping reduce bottlenecks and maintain continuity across projects without the need for permanent hires.

Quote

On behalf of the whole Market Access team: it has been a pleasure to work with such a talented team at Ciencia and we really look forward to working with you next year!

– Top 10 Global Pharma Company: Global and Nordic Market Access Teams

Jim Baker

Jim Baker
Business Development
Executive

Partner with Ciencia Research and unlock insights that power smarter decisions

Get in touch today to learn more about Ciencia Research and our services.